Table 5.

Risk factors for chronic GVH disease

Odds ratio (95% CI)P
All evaluable patients (n = 280)   
 Female to male transplantation 3.740  (1.969-7.529) < .0001  
 Diagnosis of ALL 0.384  (0.184-0.773) .0072  
Patients with CD34, T, and NK cell numbers available (n = 222)   
 Female to male transplantation 5.267  (2.489-12.316) < .0001  
 Diagnosis of ALL 0.414  (0.178-0.923) .031  
 T-cell number5-150 1.003  (1.001-1.004) < .0001  
 CD34 number5-151 0.941  (0.867-0.994) .025  
 Acute GVH disease above stage 2 2.707  (1.443-5.180) .0018 
Odds ratio (95% CI)P
All evaluable patients (n = 280)   
 Female to male transplantation 3.740  (1.969-7.529) < .0001  
 Diagnosis of ALL 0.384  (0.184-0.773) .0072  
Patients with CD34, T, and NK cell numbers available (n = 222)   
 Female to male transplantation 5.267  (2.489-12.316) < .0001  
 Diagnosis of ALL 0.414  (0.178-0.923) .031  
 T-cell number5-150 1.003  (1.001-1.004) < .0001  
 CD34 number5-151 0.941  (0.867-0.994) .025  
 Acute GVH disease above stage 2 2.707  (1.443-5.180) .0018 
F5-150

Odds ratio per unit increase in T-cell number, × 106/kg.

F5-151

Odds ratio per unit increase in CD34 cell number, × 106/kg.

[ViewLarge]
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal